全文获取类型
收费全文 | 2218篇 |
免费 | 308篇 |
国内免费 | 65篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 14篇 |
妇产科学 | 22篇 |
基础医学 | 127篇 |
口腔科学 | 41篇 |
临床医学 | 194篇 |
内科学 | 172篇 |
皮肤病学 | 28篇 |
神经病学 | 51篇 |
特种医学 | 55篇 |
外国民族医学 | 4篇 |
外科学 | 144篇 |
综合类 | 392篇 |
预防医学 | 51篇 |
眼科学 | 43篇 |
药学 | 213篇 |
1篇 | |
中国医学 | 758篇 |
肿瘤学 | 278篇 |
出版年
2024年 | 5篇 |
2023年 | 41篇 |
2022年 | 84篇 |
2021年 | 154篇 |
2020年 | 151篇 |
2019年 | 111篇 |
2018年 | 104篇 |
2017年 | 126篇 |
2016年 | 144篇 |
2015年 | 161篇 |
2014年 | 255篇 |
2013年 | 219篇 |
2012年 | 170篇 |
2011年 | 174篇 |
2010年 | 114篇 |
2009年 | 99篇 |
2008年 | 68篇 |
2007年 | 53篇 |
2006年 | 51篇 |
2005年 | 31篇 |
2004年 | 40篇 |
2003年 | 45篇 |
2002年 | 31篇 |
2001年 | 18篇 |
2000年 | 22篇 |
1999年 | 19篇 |
1998年 | 12篇 |
1997年 | 9篇 |
1996年 | 3篇 |
1995年 | 17篇 |
1994年 | 12篇 |
1993年 | 6篇 |
1992年 | 11篇 |
1991年 | 7篇 |
1990年 | 8篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1986年 | 1篇 |
1985年 | 5篇 |
1984年 | 2篇 |
1981年 | 3篇 |
1980年 | 1篇 |
1978年 | 1篇 |
排序方式: 共有2591条查询结果,搜索用时 203 毫秒
1.
三阴性乳腺癌(triple negative breast cancer,TNBC)是雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)及人类表皮生长因子受体(human epidermal growth factor-2,HER-2)均不表达的乳腺癌。按其功能特征可归纳为5类分子分型:以DNA修复缺陷或生长因子为途径的基底细胞样三阴性乳腺癌;以上皮-间充质转化和肿瘤干细胞为特征的间质样三阴性乳腺癌;免疫调节型三阴性乳腺癌;雄激素受体过表达的管腔/分泌型三阴性乳腺癌;HER-2富集型三阴性乳腺癌。三阴性乳腺癌恶性程度高且异型性较大,其治疗困难且预后较差,内分泌治疗及靶向治疗不敏感。目前很多学者对于三阴性乳腺癌的治疗各有研究,并有临床试验证实下述治疗有效。 相似文献
2.
3.
Haya Mohammed BSc MChB M. Yousuf Salmasi MRCS Massimo Caputo PhD Gianni D. Angelini PhD Hunaid A. Vohra PhD 《Journal of cardiac surgery》2020,35(6):1209-1219
Background
Limited data exists demonstrating the efficacy of minimally invasive surgery (MIS) compared to median sternotomy (MS) for multiple valvular disease (MVD). This systematic review and meta-analysis aims to compare operative and peri-operative outcomes of MIS vs MS in MVD.Methods
PubMed, Ovid, and Embase were searched from inception until August 2019 for randomized and observational studies comparing MIS and MS in patients with MVD. Clinical outcomes of intra- and postoperative times, reoperation for bleeding and surgical site infection were evaluated.Results
Five observational studies comparing 340 MIS vs 414 MS patients were eligible for qualitative and quantitative review. The quality of evidence assessed using the Newcastle-Ottawa scale was good for all included studies. Meta-analysis demonstrated increased cardiopulmonary bypass time for MIS patients (weighted mean difference [WMD], 0.487; 95% confidence interval [CI], 0.365-0.608; P < .0001). Similarly, aortic cross-clamp time was longer in patients undergoing MIS (WMD, 0.632; 95% CI, 0.509-0.755; P < .0001). No differences were found in operative mortality, reoperation for bleeding, surgical site infection, or hospital stay.Conclusions
MIS for MVD have similar short-term outcomes compared to MS. This adds value to the use of minimally invasive methods for multivalvular surgery, despite conferring longer operative times. However, the paucity in literature and learning curve associated with MIS warrants further evidence, ideally randomized control trials, to support these findings.4.
三焦作为六腑之一,是通行水、气和火的通路,与肾具有密切的生理病理性联系。三焦失调是引起慢性肾脏病(chronic kidney disease,CKD)肾阳亏虚、气机逆乱,以及痰湿、血瘀、浊毒等病理产物形成的重要病机,通调三焦法则需贯穿CKD治疗全过程。通调三焦水道的关键在于宣肺利水、淡渗利湿,通调三焦气道的关键在于和解少阳、调畅气机,通调三焦火道的关键在于温补脾肾。三焦调畅,则肺、脾、肾功能正常,气、血、水运行协调,有利于延缓CKD进展。 相似文献
5.
目的:比较雷贝拉唑三联疗法与兰索拉唑三联疗法治疗幽门螺杆菌阳性消化性溃疡的疗效。方法:将幽门螺杆菌阳性的消化性溃疡83例分为两组:治疗组(雷贝拉唑三联疗法组)41例,以雷贝拉唑10mg,阿莫西林1000mg及甲硝唑400mg每日2次口服,治疗1周后单独服用雷贝拉唑10mg,连服7d;对照组(兰索拉唑三联疗法组)42例:以兰索拉唑30mg,阿莫西林1000mg及甲硝唑400mg,每日2次口服,治疗1周后单独服用兰索拉唑30mg,连服7d。治疗期间每周门诊随诊,记录临床症状改善情况,用药结束1个月后复查胃镜并检测幽门螺杆菌结果。结果:治疗组和对照组1d的临床症状缓解率分别为80%、60%,差异有统计学意义(P<0.05);1周后症状缓解率均为98%。治疗组和对照组的溃疡愈合率分别为93%和76%,差异有统计学意义(P<0.05);治疗组和对照组的总有效率分别为98%和96%,差异无统计学意义(P>0.05)。治疗组和对照组的幽门螺杆菌根除率分别85%和81%,差异无统计学意义(P>0.05)。结论:两组方案均能有效治疗消化性溃疡和缓解临床症状,并能有效地根除幽门螺杆菌。但雷贝拉唑三联疗法在改善临床症状和促进溃疡愈合方面优于兰索拉唑三联疗法。 相似文献
6.
7.
目的:观察壮医针挑并艾灸对糖尿病周围神经病变200例的疗效。方法:取龙路、火路网络在体表的反应穴或皮下反应点,每次选2~3个穴位,持针尖快速刺入皮肤0.1~0.2cm,绞断表皮少许纤维,尽量不出血,每3天1次,配合艾灸,10次为1疗程。结果:显效102例,有效78例,无效20例。总有效率为90%。结论:壮医针挑并艾灸治疗糖尿病周围神经病变疗效仍显著。 相似文献
8.
H. Isoniemi J. Ahonen B. Eklund K. Höckerstedt K. Salmela E. von Willebrand P. Häyry 《Transplant international》1990,3(2):92-97
We have investigated the impact of triple drug immunosuppression on the occurrence of early inflammatory episodes, as detected by fine needle aspiration biopsy, and of episodes of clinical rejection during the immediate postoperative period. The prospective component of this study includes 128 consecutive first cadaveric renal transplant recipients receiving triple drug treatment consisting of azathioprine (Aza), cyclosporin (CyA) and methylprednisolone (MP). For controls we have used three historical groups: one immunosuppressed with Aza and MP (group A), another with CyA monotherapy (group B), and the third with CyA together with MP (group C) in equivalent drug dosages. On the average, 0.8 episodes of inflammation per patient were recorded during the immediate postoperative period of 30 days with triple drug treatment. This was significantly less than the 1.3 episodes in patients receiving Aza and MP (P<0.01), the 1.7 episodes in patients on CyA monotherapy (P<0.001), or the 1.6 episodes in patients receiving CyA together with MP (P<0.001). Although the first episode of inflammation commenced concurrently in each group and the peak intensity of inflammation was the same, the mean duration of inflammation was significantly shorter-2.7 days-under triple drug treatment than the 7.8–11.7 days for controls (P<0.001). The frequency of rejection episodes under triple treatment was also significantly lower-0.2 per patient-than the 0.8 per patient in controls (P<0.001). The first rejection episode occurred later in the triple drug treatment group-on the average, on day 15.2-than in the historical controls (on days 7.7–11.7). There was, however, no difference in the duration of rejection. There were no differences in patient survival between the four groups. Graft survival was 97% at 10 weeks for triple drug-treated recipients and 79%, 68%, and 87% for first grafts in groups A, B, and C, respectively. Disregarding a minor demographic bias for the triple drugtreated group with respect to preformed antibodies and preoperative dialysis treatment, the study suggests that the triple drug protocol, in the short run, is superior to any conceivable double drug combination or CyA monotherapy. 相似文献
9.
Tammar Kushnir Tatyana Knubovets Yacov Itzchak Uzi Eliav Menachem Sadeh Lubov Rapoport Edna Kott Gil Navon 《Magnetic resonance in medicine》1997,37(2):192-196
Myotonic dystrophy is an inherited multi-system disease. Its pathophysiology leading to muscle malfunction and damage is not well understood. 23Na NMR spectroscopy was applied here for an in vivo comparative study of the calf muscles of 7 myotonic dystrophy patients at various stages of the disease and 11 healthy volunteers. Both the total sodium content, expressed as the ratio of the 23Na and 1H water signals, and the fast transverse relaxation time, T21, determined from the triple quantum-filtered spectra, increased in correlation with the severity of the disease. The results demonstrate that 23Na NMR enables the quantitation of myotonic dystrophy progression. 相似文献